This research report provides a comprehensive analysis of the Chemotherapy-Induced Nausea and Vomiting Drugs market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Chemotherapy-Induced Nausea and Vomiting Drugs market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Chemotherapy-Induced Nausea and Vomiting Drugs, challenges faced by the industry, and potential opportunities for market players.
The global Chemotherapy-Induced Nausea and Vomiting Drugs market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Chemotherapy-Induced Nausea and Vomiting Drugs market presents opportunities for various stakeholders, including Serotonin Receptor Antagonists, NK1 Receptor Antagonists. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Chemotherapy-Induced Nausea and Vomiting Drugs market. Additionally, the growing consumer demand present avenues for market expansion.
The global Chemotherapy-Induced Nausea and Vomiting Drugs market was valued at US$ 2421.7 million in 2023 and is projected to reach US$ 2893.9 million by 2030, at a CAGR of 2.6% during the forecast period.
Key Features:
The research report on the Chemotherapy-Induced Nausea and Vomiting Drugs market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Chemotherapy-Induced Nausea and Vomiting Drugs market.
Market Overview: The report provides a comprehensive overview of the Chemotherapy-Induced Nausea and Vomiting Drugs market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Existing Drugs, Akynzeo (Netupitant-Palonosetron FDC)), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Chemotherapy-Induced Nausea and Vomiting Drugs market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Chemotherapy-Induced Nausea and Vomiting Drugs market's trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Chemotherapy-Induced Nausea and Vomiting Drugs market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Chemotherapy-Induced Nausea and Vomiting Drugs market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Chemotherapy-Induced Nausea and Vomiting Drugs market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Chemotherapy-Induced Nausea and Vomiting Drugs market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Chemotherapy-Induced Nausea and Vomiting Drugs, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Chemotherapy-Induced Nausea and Vomiting Drugs market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Chemotherapy-Induced Nausea and Vomiting Drugs market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Existing Drugs
Akynzeo (Netupitant-Palonosetron FDC)
Aloxi (Palonosetron)
Emend (Aprepitant)
Kytril Generic (Granisetron)
Zofran Generic (Ondansetron)
Pipeline Drugs
SUSTOL (Granisetron Injection extended release)
Rolapitant
Market segment by Application
Serotonin Receptor Antagonists
NK1 Receptor Antagonists
Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Merck & Co., Inc.
GlaxoSmithKline plc
Tesaro, Inc.
Helsinn Group
F. Hoffmann-La Roche Ltd.
Heron Therapeutics, Inc.
Dr. Reddy's Laboratories Ltd.
Acacia Pharma
Sun Pharmaceutical Industry Ltd.
Otsuka Holdings Co., Ltd.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Chemotherapy-Induced Nausea and Vomiting Drugs, market overview.
Chapter 2: Global Chemotherapy-Induced Nausea and Vomiting Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Chemotherapy-Induced Nausea and Vomiting Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Chemotherapy-Induced Nausea and Vomiting Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Chemotherapy-Induced Nausea and Vomiting Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Chemotherapy-Induced Nausea and Vomiting Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Overall Market Size
2.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Size: 2023 VS 2030
2.2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, Prospects & Forecasts: 2019-2030
2.3 Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales: 2019-2030
3 Company Landscape
3.1 Top Chemotherapy-Induced Nausea and Vomiting Drugs Players in Global Market
3.2 Top Global Chemotherapy-Induced Nausea and Vomiting Drugs Companies Ranked by Revenue
3.3 Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Companies
3.4 Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Companies
3.5 Global Chemotherapy-Induced Nausea and Vomiting Drugs Price by Manufacturer (2019-2024)
3.6 Top 3 and Top 5 Chemotherapy-Induced Nausea and Vomiting Drugs Companies in Global Market, by Revenue in 2023
3.7 Global Manufacturers Chemotherapy-Induced Nausea and Vomiting Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Chemotherapy-Induced Nausea and Vomiting Drugs Players in Global Market
3.8.1 List of Global Tier 1 Chemotherapy-Induced Nausea and Vomiting Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Chemotherapy-Induced Nausea and Vomiting Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Size Markets, 2023 & 2030
4.1.2 Existing Drugs
4.1.3 Akynzeo (Netupitant-Palonosetron FDC)
4.1.4 Aloxi (Palonosetron)
4.1.5 Emend (Aprepitant)
4.1.6 Kytril Generic (Granisetron)
4.1.7 Zofran Generic (Ondansetron)
4.1.8 Pipeline Drugs
4.1.9 SUSTOL (Granisetron Injection extended release)
4.1.10 Rolapitant
4.2 By Type - Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue & Forecasts
4.2.1 By Type - Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, 2019-2024
4.2.2 By Type - Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, 2025-2030
4.2.3 By Type - Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share, 2019-2030
4.3 By Type - Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales & Forecasts
4.3.1 By Type - Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales, 2019-2024
4.3.2 By Type - Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales, 2025-2030
4.3.3 By Type - Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share, 2019-2030
4.4 By Type - Global Chemotherapy-Induced Nausea and Vomiting Drugs Price (Manufacturers Selling Prices), 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Size, 2023 & 2030
5.1.2 Serotonin Receptor Antagonists
5.1.3 NK1 Receptor Antagonists
5.2 By Application - Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue & Forecasts
5.2.1 By Application - Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, 2019-2024
5.2.2 By Application - Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, 2025-2030
5.2.3 By Application - Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share, 2019-2030
5.3 By Application - Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales & Forecasts
5.3.1 By Application - Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales, 2019-2024
5.3.2 By Application - Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales, 2025-2030
5.3.3 By Application - Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share, 2019-2030
5.4 By Application - Global Chemotherapy-Induced Nausea and Vomiting Drugs Price (Manufacturers Selling Prices), 2019-2030
6 Sights by Region
6.1 By Region - Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Size, 2023 & 2030
6.2 By Region - Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue & Forecasts
6.2.1 By Region - Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, 2019-2024
6.2.2 By Region - Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, 2025-2030
6.2.3 By Region - Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share, 2019-2030
6.3 By Region - Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales & Forecasts
6.3.1 By Region - Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales, 2019-2024
6.3.2 By Region - Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales, 2025-2030
6.3.3 By Region - Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share, 2019-2030
6.4 North America
6.4.1 By Country - North America Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, 2019-2030
6.4.2 By Country - North America Chemotherapy-Induced Nausea and Vomiting Drugs Sales, 2019-2030
6.4.3 US Chemotherapy-Induced Nausea and Vomiting Drugs Market Size, 2019-2030
6.4.4 Canada Chemotherapy-Induced Nausea and Vomiting Drugs Market Size, 2019-2030
6.4.5 Mexico Chemotherapy-Induced Nausea and Vomiting Drugs Market Size, 2019-2030
6.5 Europe
6.5.1 By Country - Europe Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, 2019-2030
6.5.2 By Country - Europe Chemotherapy-Induced Nausea and Vomiting Drugs Sales, 2019-2030
6.5.3 Germany Chemotherapy-Induced Nausea and Vomiting Drugs Market Size, 2019-2030
6.5.4 France Chemotherapy-Induced Nausea and Vomiting Drugs Market Size, 2019-2030
6.5.5 U.K. Chemotherapy-Induced Nausea and Vomiting Drugs Market Size, 2019-2030
6.5.6 Italy Chemotherapy-Induced Nausea and Vomiting Drugs Market Size, 2019-2030
6.5.7 Russia Chemotherapy-Induced Nausea and Vomiting Drugs Market Size, 2019-2030
6.5.8 Nordic Countries Chemotherapy-Induced Nausea and Vomiting Drugs Market Size, 2019-2030
6.5.9 Benelux Chemotherapy-Induced Nausea and Vomiting Drugs Market Size, 2019-2030
6.6 Asia
6.6.1 By Region - Asia Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, 2019-2030
6.6.2 By Region - Asia Chemotherapy-Induced Nausea and Vomiting Drugs Sales, 2019-2030
6.6.3 China Chemotherapy-Induced Nausea and Vomiting Drugs Market Size, 2019-2030
6.6.4 Japan Chemotherapy-Induced Nausea and Vomiting Drugs Market Size, 2019-2030
6.6.5 South Korea Chemotherapy-Induced Nausea and Vomiting Drugs Market Size, 2019-2030
6.6.6 Southeast Asia Chemotherapy-Induced Nausea and Vomiting Drugs Market Size, 2019-2030
6.6.7 India Chemotherapy-Induced Nausea and Vomiting Drugs Market Size, 2019-2030
6.7 South America
6.7.1 By Country - South America Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, 2019-2030
6.7.2 By Country - South America Chemotherapy-Induced Nausea and Vomiting Drugs Sales, 2019-2030
6.7.3 Brazil Chemotherapy-Induced Nausea and Vomiting Drugs Market Size, 2019-2030
6.7.4 Argentina Chemotherapy-Induced Nausea and Vomiting Drugs Market Size, 2019-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, 2019-2030
6.8.2 By Country - Middle East & Africa Chemotherapy-Induced Nausea and Vomiting Drugs Sales, 2019-2030
6.8.3 Turkey Chemotherapy-Induced Nausea and Vomiting Drugs Market Size, 2019-2030
6.8.4 Israel Chemotherapy-Induced Nausea and Vomiting Drugs Market Size, 2019-2030
6.8.5 Saudi Arabia Chemotherapy-Induced Nausea and Vomiting Drugs Market Size, 2019-2030
6.8.6 UAE Chemotherapy-Induced Nausea and Vomiting Drugs Market Size, 2019-2030
7 Manufacturers & Brands Profiles
7.1 Merck & Co., Inc.
7.1.1 Merck & Co., Inc. Company Summary
7.1.2 Merck & Co., Inc. Business Overview
7.1.3 Merck & Co., Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Major Product Offerings
7.1.4 Merck & Co., Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales and Revenue in Global (2019-2024)
7.1.5 Merck & Co., Inc. Key News & Latest Developments
7.2 GlaxoSmithKline plc
7.2.1 GlaxoSmithKline plc Company Summary
7.2.2 GlaxoSmithKline plc Business Overview
7.2.3 GlaxoSmithKline plc Chemotherapy-Induced Nausea and Vomiting Drugs Major Product Offerings
7.2.4 GlaxoSmithKline plc Chemotherapy-Induced Nausea and Vomiting Drugs Sales and Revenue in Global (2019-2024)
7.2.5 GlaxoSmithKline plc Key News & Latest Developments
7.3 Tesaro, Inc.
7.3.1 Tesaro, Inc. Company Summary
7.3.2 Tesaro, Inc. Business Overview
7.3.3 Tesaro, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Major Product Offerings
7.3.4 Tesaro, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales and Revenue in Global (2019-2024)
7.3.5 Tesaro, Inc. Key News & Latest Developments
7.4 Helsinn Group
7.4.1 Helsinn Group Company Summary
7.4.2 Helsinn Group Business Overview
7.4.3 Helsinn Group Chemotherapy-Induced Nausea and Vomiting Drugs Major Product Offerings
7.4.4 Helsinn Group Chemotherapy-Induced Nausea and Vomiting Drugs Sales and Revenue in Global (2019-2024)
7.4.5 Helsinn Group Key News & Latest Developments
7.5 F. Hoffmann-La Roche Ltd.
7.5.1 F. Hoffmann-La Roche Ltd. Company Summary
7.5.2 F. Hoffmann-La Roche Ltd. Business Overview
7.5.3 F. Hoffmann-La Roche Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Major Product Offerings
7.5.4 F. Hoffmann-La Roche Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales and Revenue in Global (2019-2024)
7.5.5 F. Hoffmann-La Roche Ltd. Key News & Latest Developments
7.6 Heron Therapeutics, Inc.
7.6.1 Heron Therapeutics, Inc. Company Summary
7.6.2 Heron Therapeutics, Inc. Business Overview
7.6.3 Heron Therapeutics, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Major Product Offerings
7.6.4 Heron Therapeutics, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales and Revenue in Global (2019-2024)
7.6.5 Heron Therapeutics, Inc. Key News & Latest Developments
7.7 Dr. Reddy's Laboratories Ltd.
7.7.1 Dr. Reddy's Laboratories Ltd. Company Summary
7.7.2 Dr. Reddy's Laboratories Ltd. Business Overview
7.7.3 Dr. Reddy's Laboratories Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Major Product Offerings
7.7.4 Dr. Reddy's Laboratories Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales and Revenue in Global (2019-2024)
7.7.5 Dr. Reddy's Laboratories Ltd. Key News & Latest Developments
7.8 Acacia Pharma
7.8.1 Acacia Pharma Company Summary
7.8.2 Acacia Pharma Business Overview
7.8.3 Acacia Pharma Chemotherapy-Induced Nausea and Vomiting Drugs Major Product Offerings
7.8.4 Acacia Pharma Chemotherapy-Induced Nausea and Vomiting Drugs Sales and Revenue in Global (2019-2024)
7.8.5 Acacia Pharma Key News & Latest Developments
7.9 Sun Pharmaceutical Industry Ltd.
7.9.1 Sun Pharmaceutical Industry Ltd. Company Summary
7.9.2 Sun Pharmaceutical Industry Ltd. Business Overview
7.9.3 Sun Pharmaceutical Industry Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Major Product Offerings
7.9.4 Sun Pharmaceutical Industry Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales and Revenue in Global (2019-2024)
7.9.5 Sun Pharmaceutical Industry Ltd. Key News & Latest Developments
7.10 Otsuka Holdings Co., Ltd.
7.10.1 Otsuka Holdings Co., Ltd. Company Summary
7.10.2 Otsuka Holdings Co., Ltd. Business Overview
7.10.3 Otsuka Holdings Co., Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Major Product Offerings
7.10.4 Otsuka Holdings Co., Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales and Revenue in Global (2019-2024)
7.10.5 Otsuka Holdings Co., Ltd. Key News & Latest Developments
8 Global Chemotherapy-Induced Nausea and Vomiting Drugs Production Capacity, Analysis
8.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Production Capacity, 2019-2030
8.2 Chemotherapy-Induced Nausea and Vomiting Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Chemotherapy-Induced Nausea and Vomiting Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Chemotherapy-Induced Nausea and Vomiting Drugs Supply Chain Analysis
10.1 Chemotherapy-Induced Nausea and Vomiting Drugs Industry Value Chain
10.2 Chemotherapy-Induced Nausea and Vomiting Drugs Upstream Market
10.3 Chemotherapy-Induced Nausea and Vomiting Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Chemotherapy-Induced Nausea and Vomiting Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Chemotherapy-Induced Nausea and Vomiting Drugs in Global Market
Table 2. Top Chemotherapy-Induced Nausea and Vomiting Drugs Players in Global Market, Ranking by Revenue (2023)
Table 3. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Companies, (US$, Mn), 2019-2024
Table 4. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Share by Companies, 2019-2024
Table 5. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Companies, (K Units), 2019-2024
Table 6. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Share by Companies, 2019-2024
Table 7. Key Manufacturers Chemotherapy-Induced Nausea and Vomiting Drugs Price (2019-2024) & (USD/Unit)
Table 8. Global Manufacturers Chemotherapy-Induced Nausea and Vomiting Drugs Product Type
Table 9. List of Global Tier 1 Chemotherapy-Induced Nausea and Vomiting Drugs Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Chemotherapy-Induced Nausea and Vomiting Drugs Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (US$, Mn), 2019-2024
Table 13. By Type - Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (US$, Mn), 2025-2030
Table 14. By Type - Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), 2019-2024
Table 15. By Type - Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), 2025-2030
Table 16. By Application ? Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, (US$, Mn), 2023 & 2030
Table 17. By Application - Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (US$, Mn), 2019-2024
Table 18. By Application - Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (US$, Mn), 2025-2030
Table 19. By Application - Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), 2019-2024
Table 20. By Application - Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), 2025-2030
Table 21. By Region ? Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, (US$, Mn), 2023 VS 2030
Table 22. By Region - Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (US$, Mn), 2019-2024
Table 23. By Region - Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (US$, Mn), 2025-2030
Table 24. By Region - Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), 2019-2024
Table 25. By Region - Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), 2025-2030
Table 26. By Country - North America Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, (US$, Mn), 2019-2024
Table 27. By Country - North America Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, (US$, Mn), 2025-2030
Table 28. By Country - North America Chemotherapy-Induced Nausea and Vomiting Drugs Sales, (K Units), 2019-2024
Table 29. By Country - North America Chemotherapy-Induced Nausea and Vomiting Drugs Sales, (K Units), 2025-2030
Table 30. By Country - Europe Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, (US$, Mn), 2019-2024
Table 31. By Country - Europe Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, (US$, Mn), 2025-2030
Table 32. By Country - Europe Chemotherapy-Induced Nausea and Vomiting Drugs Sales, (K Units), 2019-2024
Table 33. By Country - Europe Chemotherapy-Induced Nausea and Vomiting Drugs Sales, (K Units), 2025-2030
Table 34. By Region - Asia Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, (US$, Mn), 2019-2024
Table 35. By Region - Asia Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, (US$, Mn), 2025-2030
Table 36. By Region - Asia Chemotherapy-Induced Nausea and Vomiting Drugs Sales, (K Units), 2019-2024
Table 37. By Region - Asia Chemotherapy-Induced Nausea and Vomiting Drugs Sales, (K Units), 2025-2030
Table 38. By Country - South America Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, (US$, Mn), 2019-2024
Table 39. By Country - South America Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, (US$, Mn), 2025-2030
Table 40. By Country - South America Chemotherapy-Induced Nausea and Vomiting Drugs Sales, (K Units), 2019-2024
Table 41. By Country - South America Chemotherapy-Induced Nausea and Vomiting Drugs Sales, (K Units), 2025-2030
Table 42. By Country - Middle East & Africa Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, (US$, Mn), 2019-2024
Table 43. By Country - Middle East & Africa Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, (US$, Mn), 2025-2030
Table 44. By Country - Middle East & Africa Chemotherapy-Induced Nausea and Vomiting Drugs Sales, (K Units), 2019-2024
Table 45. By Country - Middle East & Africa Chemotherapy-Induced Nausea and Vomiting Drugs Sales, (K Units), 2025-2030
Table 46. Merck & Co., Inc. Company Summary
Table 47. Merck & Co., Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Product Offerings
Table 48. Merck & Co., Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 49. Merck & Co., Inc. Key News & Latest Developments
Table 50. GlaxoSmithKline plc Company Summary
Table 51. GlaxoSmithKline plc Chemotherapy-Induced Nausea and Vomiting Drugs Product Offerings
Table 52. GlaxoSmithKline plc Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 53. GlaxoSmithKline plc Key News & Latest Developments
Table 54. Tesaro, Inc. Company Summary
Table 55. Tesaro, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Product Offerings
Table 56. Tesaro, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 57. Tesaro, Inc. Key News & Latest Developments
Table 58. Helsinn Group Company Summary
Table 59. Helsinn Group Chemotherapy-Induced Nausea and Vomiting Drugs Product Offerings
Table 60. Helsinn Group Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 61. Helsinn Group Key News & Latest Developments
Table 62. F. Hoffmann-La Roche Ltd. Company Summary
Table 63. F. Hoffmann-La Roche Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Product Offerings
Table 64. F. Hoffmann-La Roche Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 65. F. Hoffmann-La Roche Ltd. Key News & Latest Developments
Table 66. Heron Therapeutics, Inc. Company Summary
Table 67. Heron Therapeutics, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Product Offerings
Table 68. Heron Therapeutics, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 69. Heron Therapeutics, Inc. Key News & Latest Developments
Table 70. Dr. Reddy's Laboratories Ltd. Company Summary
Table 71. Dr. Reddy's Laboratories Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Product Offerings
Table 72. Dr. Reddy's Laboratories Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 73. Dr. Reddy's Laboratories Ltd. Key News & Latest Developments
Table 74. Acacia Pharma Company Summary
Table 75. Acacia Pharma Chemotherapy-Induced Nausea and Vomiting Drugs Product Offerings
Table 76. Acacia Pharma Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 77. Acacia Pharma Key News & Latest Developments
Table 78. Sun Pharmaceutical Industry Ltd. Company Summary
Table 79. Sun Pharmaceutical Industry Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Product Offerings
Table 80. Sun Pharmaceutical Industry Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 81. Sun Pharmaceutical Industry Ltd. Key News & Latest Developments
Table 82. Otsuka Holdings Co., Ltd. Company Summary
Table 83. Otsuka Holdings Co., Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Product Offerings
Table 84. Otsuka Holdings Co., Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 85. Otsuka Holdings Co., Ltd. Key News & Latest Developments
Table 86. Chemotherapy-Induced Nausea and Vomiting Drugs Production Capacity (K Units) of Key Manufacturers in Global Market, 2022-2024 (K Units)
Table 87. Global Chemotherapy-Induced Nausea and Vomiting Drugs Capacity Market Share of Key Manufacturers, 2022-2024
Table 88. Global Chemotherapy-Induced Nausea and Vomiting Drugs Production by Region, 2019-2024 (K Units)
Table 89. Global Chemotherapy-Induced Nausea and Vomiting Drugs Production by Region, 2025-2030 (K Units)
Table 90. Chemotherapy-Induced Nausea and Vomiting Drugs Market Opportunities & Trends in Global Market
Table 91. Chemotherapy-Induced Nausea and Vomiting Drugs Market Drivers in Global Market
Table 92. Chemotherapy-Induced Nausea and Vomiting Drugs Market Restraints in Global Market
Table 93. Chemotherapy-Induced Nausea and Vomiting Drugs Raw Materials
Table 94. Chemotherapy-Induced Nausea and Vomiting Drugs Raw Materials Suppliers in Global Market
Table 95. Typical Chemotherapy-Induced Nausea and Vomiting Drugs Downstream
Table 96. Chemotherapy-Induced Nausea and Vomiting Drugs Downstream Clients in Global Market
Table 97. Chemotherapy-Induced Nausea and Vomiting Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Chemotherapy-Induced Nausea and Vomiting Drugs Segment by Type in 2023
Figure 2. Chemotherapy-Induced Nausea and Vomiting Drugs Segment by Application in 2023
Figure 3. Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, 2019-2030 (US$, Mn)
Figure 7. Chemotherapy-Induced Nausea and Vomiting Drugs Sales in Global Market: 2019-2030 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Chemotherapy-Induced Nausea and Vomiting Drugs Revenue in 2023
Figure 9. By Type - Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, (US$, Mn), 2023 & 2030
Figure 10. By Type - Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share, 2019-2030
Figure 11. By Type - Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share, 2019-2030
Figure 12. By Type - Global Chemotherapy-Induced Nausea and Vomiting Drugs Price (USD/Unit), 2019-2030
Figure 13. By Application - Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, (US$, Mn), 2023 & 2030
Figure 14. By Application - Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share, 2019-2030
Figure 15. By Application - Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share, 2019-2030
Figure 16. By Application - Global Chemotherapy-Induced Nausea and Vomiting Drugs Price (USD/Unit), 2019-2030
Figure 17. By Region - Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, (US$, Mn), 2023 & 2030
Figure 18. By Region - Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share, 2019 VS 2023 VS 2030
Figure 19. By Region - Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share, 2019-2030
Figure 20. By Region - Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share, 2019-2030
Figure 21. By Country - North America Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share, 2019-2030
Figure 22. By Country - North America Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share, 2019-2030
Figure 23. US Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, (US$, Mn), 2019-2030
Figure 24. Canada Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, (US$, Mn), 2019-2030
Figure 25. Mexico Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, (US$, Mn), 2019-2030
Figure 26. By Country - Europe Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share, 2019-2030
Figure 27. By Country - Europe Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share, 2019-2030
Figure 28. Germany Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, (US$, Mn), 2019-2030
Figure 29. France Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, (US$, Mn), 2019-2030
Figure 30. U.K. Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, (US$, Mn), 2019-2030
Figure 31. Italy Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, (US$, Mn), 2019-2030
Figure 32. Russia Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, (US$, Mn), 2019-2030
Figure 33. Nordic Countries Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, (US$, Mn), 2019-2030
Figure 34. Benelux Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, (US$, Mn), 2019-2030
Figure 35. By Region - Asia Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share, 2019-2030
Figure 36. By Region - Asia Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share, 2019-2030
Figure 37. China Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, (US$, Mn), 2019-2030
Figure 38. Japan Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, (US$, Mn), 2019-2030
Figure 39. South Korea Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, (US$, Mn), 2019-2030
Figure 40. Southeast Asia Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, (US$, Mn), 2019-2030
Figure 41. India Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, (US$, Mn), 2019-2030
Figure 42. By Country - South America Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share, 2019-2030
Figure 43. By Country - South America Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share, 2019-2030
Figure 44. Brazil Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, (US$, Mn), 2019-2030
Figure 45. Argentina Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, (US$, Mn), 2019-2030
Figure 46. By Country - Middle East & Africa Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share, 2019-2030
Figure 47. By Country - Middle East & Africa Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share, 2019-2030
Figure 48. Turkey Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, (US$, Mn), 2019-2030
Figure 49. Israel Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, (US$, Mn), 2019-2030
Figure 50. Saudi Arabia Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, (US$, Mn), 2019-2030
Figure 51. UAE Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, (US$, Mn), 2019-2030
Figure 52. Global Chemotherapy-Induced Nausea and Vomiting Drugs Production Capacity (K Units), 2019-2030
Figure 53. The Percentage of Production Chemotherapy-Induced Nausea and Vomiting Drugs by Region, 2023 VS 2030
Figure 54. Chemotherapy-Induced Nausea and Vomiting Drugs Industry Value Chain
Figure 55. Marketing Channels
